Stevanato Group

Stevanato Group, founded in 1949, is a global leader in integrated containment and delivery solutions for the biopharmaceutical industry. The company's expertise lies in its proprietary glass forming technology, ensuring the highest quality standards for its products. With a diverse portfolio, including glass containers under the Ompi brand, plastic components for diagnostics and medical devices, contract manufacturing services for drug delivery systems, and inspection, assembly, and packaging machines, Stevanato Group caters to the entire biopharmaceutical and diagnostic industry. An important differentiator for the group is its provision of analytical services and tests that focus on the interaction between the container and drug, aiding integration into delivery systems and supporting the drug development process. By consolidating these diverse capabilities, Stevanato Group uniquely offers solutions that reduce both time to market and overall costs for companies in the biopharmaceutical sector. Notably, the company's most recent milestone includes a significant $330.00M Post-IPO Equity investment at 21 March 2024, signifying confidence in its growth trajectory. Headquartered in Italy, Stevanato Group continues to demonstrate its integral role in shaping the future of the biopharmaceutical industry.